Vassort Guy, Bideaux Patrice, Alvarez Julio
Physiopathologie Cardiovasculaire, INSERM U-637, Université Montpellier 1, CHU Arnaud de Villeneuve, Montpellier, France;
Exp Clin Cardiol. 2010 Winter;15(4):e104-8.
Despite its degradation by ectonucleotidases, a low ATP concentration is present in the interstitial space; moreover, its level can markedly increase during various physiopathological conditions. ATP and uridine 5'-triphosphate (UTP) releases correlate with the occurrence of ventricular premature beats and ventricular tachycardia. ATP facilitates several voltage-dependent ionic currents including the L-type Ca(2+) current. More recently, ATP and UTP were also shown to induce a poor voltage-dependent, long-lasting current carried by the heterotetrameric transient receptor potential (TRP) channels TRPC3/7. ATP effects result from its binding to metabotropic P2Y2 receptors that lead to diacylglycerol formation and activation of phospholipase Cβ and inositol-1,4,5-triphosphate production. ATP also favours TRPM4 activation by increasing Ca(2+) release from the sarcoplasmic reticulum. Indeed, TRPM4 current properties match those of the Ca(2+)-activated, nonselective cationic current supporting the delayed afterdepolarizations observed under conditions of Ca(2+) overload. In the present article, it was hypothesized that creatine, at a relatively high concentration, would serve as a buffer for the sudden release of ATP and UTP during the early phase of ischemia in association with previously described arrhythmic events. The potential preventive effect of creatine was tested by analyzing its ability to antagonize the arrhythmia that occurred on inducing a coronary ligature in rats that were or were not preinjected with creatine. Electrocardiogram recordings of creatine-injected rats clearly demonstrated that both ventricular premature beats and, particularly, ventricular tachycardia markedly decreased. The effect of creatine was even more striking in early deaths. However, an injection of beta-guanidinopropionate, a creatine analogue with 1000-fold lower kinetics, had no significant protective effect.
尽管其会被外核苷酸酶降解,但间质空间中仍存在低浓度的三磷酸腺苷(ATP);此外,在各种生理病理条件下其水平会显著升高。ATP和尿苷5'-三磷酸(UTP)的释放与室性早搏和室性心动过速的发生相关。ATP促进多种电压依赖性离子电流,包括L型钙电流。最近,ATP和UTP还被证明可诱导由异源四聚体瞬时受体电位(TRP)通道TRPC3/7携带的电压依赖性差、持续时间长的电流。ATP的作用源于其与代谢型P2Y2受体结合,导致二酰甘油形成并激活磷脂酶Cβ以及产生肌醇-1,4,5-三磷酸。ATP还通过增加肌浆网中钙的释放促进瞬时受体电位阳离子通道蛋白4(TRPM4)的激活。事实上,TRPM4电流特性与钙激活的非选择性阳离子电流特性相符,支持在钙超载条件下观察到的延迟后去极化。在本文中,有人提出假设,相对高浓度的肌酸会在缺血早期与先前描述的心律失常事件相关联时,作为ATP和UTP突然释放的缓冲剂。通过分析肌酸对在冠状动脉结扎诱导心律失常的大鼠(预先注射或未预先注射肌酸)中对抗心律失常的能力,来测试肌酸的潜在预防作用。对注射肌酸的大鼠进行心电图记录清楚地表明,室性早搏,特别是室性心动过速明显减少。肌酸在早期死亡中的作用更为显著。然而,注射动力学比肌酸低1000倍的肌酸类似物β-胍基丙酸,没有显著的保护作用。